九州通 Stock: price and insider trades · China
2 insiders bought €274k of shares over the last 90 days, the latest by 刘长云, filed 29 Oct 2026.
Cluster: 2 buyers in 30 days九州通: what insiders have been doing
九州通 is a listed company. Its insiders report their share dealings to SSE / SZSE (CSRC). Over the twelve months to 2 November 2026, 2 filings were filed, from 2 insiders.
The flow runs one way only: 2 insiders bought (2 purchases totalling €274k) and nobody sold on the market. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The largest single trade was a purchase of €139k by 龚翼华, published on 29 October 2026. The buyers include 2 chief executives.
With 2 filings in twelve months, the company is in line with the median of 2 filings across the 512 companies we follow on the same exchange. Our records for 九州通 go back to 2026, with 2 purchases and no sales on the open market in total.
The data flag 2 purchases as part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. The latest purchase is recent: it was published 10 days ago, on 29 October 2026.
Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.
Who traded when
BuySaleAnalyst consensus: bullish or bearish?
Analysts rate 九州通 Buy (bullish), based on 4 analysts. Average price target: CN¥5.76.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
About 九州通
Kyushu Tong is a company listed on the Shanghai Stock Exchange, specializing in the distribution of medical and pharmaceutical products. It plays a key role in the healthcare supply chain in China.